Abstract
Vulnerability in research is often understood as a diminished ability to protect one's own interests, manifested by a compromised capacity to give informed or voluntary consent. Certain groups of people are thought to be more vulnerable than others and therefore are at risk of being exploited or mistreated in research. Accordingly, the federal regulations call for additional safeguards to protect vulnerable groups.There remains some ambiguity and contradiction, however, regarding what groups are vulnerable in research and why,3 since the available codes of research ethics and regulations describe many groups as vulnerable. When so many groups are considered vulnerable, but no specification is offered as to how they are vulnerable or what particular protections are appropriate, the possibility of meaningful safeguards is diminished. In addition, current concepts of vulnerability are usually applied to whole groups of people, without distinguishing between individuals in a group who might truly have a compromised capacity to protect their own interests from those who do not.
Publisher
Cambridge University Press (CUP)
Subject
Health Policy,General Medicine,Issues, ethics and legal aspects
Reference48 articles.
1. The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations
2. Enrollment of African Americans Onto Clinical Treatment Trials: Study Design Barriers
3. 10. See National Commission, supra note 6.
4. 26. Grady, C. Pace, C. Campbell, B. Emanuel, E. , “The Quality of Informed Consent for Clinical Research: A Comparative Review of Empirical Data from Developing and Developed Countries” (unpublished manuscript).
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献